CRISPR Therapeutics AG

Halal Rating :
See Details
Last Price $60.58 Last updated:
Market Cap $4.57b
7D Change 0.01%
1 Year Change 0.01%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing
Exchange NASDAQ
Next Earnings Date Feb. 20, 2024

CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
March 31, 2024 $504000.0 $159.04m - - 0.00% 0.00%
Dec. 31, 2023 $201.34m $165.9m - $17.79m 0.00% 10.73%

Company Impact

Help us evaluate CRISPR Therapeutics AG's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates